We are creating the world's most trusted encyclopedia and knowledge base. Once you join us and log in, you'll be able to edit this page instantly!

From Citizendium, the Citizens' Compendium

Angiotensin-converting enzyme inhibitors (commonly ACE inhibitors) are a "class of drugs whose main indications are the treatment of hypertension and heart failure. They exert their hemodynamic effect mainly by inhibiting the renin-angiotensin system. They also modulate sympathetic nervous system activity and increase prostaglandin synthesis. They cause mainly vasodilation and mild natriuresis without affecting heart rate and contractility."^[1]

Angiotensin-converting enzyme inhibitors also decrease the degradation of bradykinin as the enzyme kininase II is the same enzyme as angiotensin-converting enzyme.^[2] This may contribute to some patients having a cough when taking angiotensin-converting enzyme inhibitors.

Contents 1 Uses 1.1 Hypertension 1.2 Heart failure 1.3 Chronic kidney disease 2 Adverse effects 2.1 Cough 3 References

Uses

Hypertension

For more information, see: Hypertension

In hypertension, all ACE inhibitors have a similar degree of lowering the blood pressure.^[3]. At half of the maximum dose, the average reduction in blood pressure is -8/-5 mm Hg.

Heart failure

For more information, see: Heart failure

Chronic kidney disease

For more information, see: Chronic kidney disease

Adverse effects

Cough

According to a clinical prediction rule, cough due to angiotensin-converting enzyme inhibitors is more likely among patients who are "older age, female gender, non-African American (with East Asian having highest risk), no history of previous angiotensin-converting enzyme inhibitor use, and history of cough due to another angiotensin-converting enzyme inhibitor".^[4]

References

1. ↑ Anonymous, (2008) Angiotensin-converting enzyme inhibitors (English). Medical Subject Headings. U.S. National Library of Medicine.
2. ↑ Gainer JV, Morrow JD, Loveland A, King DJ, Brown NJ (October 1998). "Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects". N. Engl. J. Med. 339 (18): 1285–92. PMID 9791144.
3. ↑ Heran BS, Wong MM, Heran IK, Wright JM (2008). "Blood pressure lowering efficacy of angiotensin converting enzyme (ACE) inhibitors for primary hypertension". Cochrane database of systematic reviews (Online) (4): CD003823. DOI:10.1002/14651858.CD003823.pub2. PMID 18843651.
4. ↑ Morimoto T, Gandhi TK, Fiskio JM, et al (June 2004). "Development and validation of a clinical prediction rule for angiotensin-converting enzyme inhibitor-induced cough". J Gen Intern Med 19 (6): 684–91. DOI:10.1111/j.1525-1497.2004.30016.x. PMID 15209608.